Format

Send to

Choose Destination
Int J Tuberc Lung Dis. 2017 Jul 1;21(7):746-752. doi: 10.5588/ijtld.16.0699.

Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.

Author information

1
Division of Pulmonary and Critical Care Medicine, University of California San Francisco and Zuckerberg San Francisco General Hospital, San Francisco, Curry International Tuberculosis Center, University of California San Francisco, San Francisco, California, USA.
2
School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
3
Faculty of Infectious and Tropical Diseases and TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
4
Uganda National Tuberculosis and Leprosy Control Programme, Kampala.
5
School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
6
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
7
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

Abstract

OBJECTIVE:

To assess the feasibility of a streamlined strategy for improving tuberculosis (TB) diagnostic evaluation and treatment initiation among patients with presumed TB.

DESIGN:

Single-arm interventional pilot study at five primary care health centers of a streamlined, SIngle-saMPLE (SIMPLE) TB diagnostic evaluation strategy: 1) examination of two smear results from a single spot sputum specimen using light-emitting diode fluorescence microscopy, and 2) daily transportation of smear-negative sputum samples to Xpert® MTB/RIF testing sites.

RESULTS:

Of 1212 adults who underwent sputum testing for TB, 99.6% had two smears examined from the spot sputum specimen. Sputum was transported for Xpert testing within 1 clinic day for 83% (907/1091) of the smear-negative patients. Of 157 (13%) patients with bacteriologically positive TB, 116 (74%) were identified using sputum smear microscopy and 41 (26%) using Xpert testing of smear-negative samples. Anti-tuberculosis treatment was initiated in 142 (90%) patients with bacteriologically positive TB, with a median time to treatment of 1 day for smear-positive patients and 6 days for smear-negative, Xpert-positive patients.

CONCLUSION:

The SIMPLE TB strategy led to successful incorporation of Xpert testing and rapid treatment initiation in the majority of patients with bacteriologically confirmed TB in a resource-limited setting.

Comment in

PMID:
28633698
PMCID:
PMC5479151
DOI:
10.5588/ijtld.16.0699
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ingenta plc Icon for PubMed Central
Loading ...
Support Center